Neuropsychopharmacology Reviews: Neurotherapeutics

The brain is a daunting therapeutic challenge. This year's edition of Neuropsychopharmacology Reviews provides an update on treatments for brain disorders ranging from schizophrenia to neurodegeneration. Join Kerri Smith as she talks to Gwenn Smith, editor of this year's volume, about current therapies such as drugs, electrical stimulation and cognitive therapies, and the future of neurotherapeutics in an era of uncertain funding.

Hosted on Acast. See acast.com/privacy for more information.

More from NPP BrainPod

  1. 09:08Spotlighting SHAPERS: Sex hormones associated with psychological and endocrine rolesMar 05, 2024
  2. 09:33Comparable roles for serotonin in rats and humans for computations underlying flexible decision-makingJan 04, 2024
  3. 09:58Integrating public health and translational basic science to address challenges of xylazine adulteration of fentanylOct 16, 2023
  4. 08:29The why, when, where, how, and so what of so-called rapidly acting antidepressantsSep 06, 2023
  5. 09:09AI-based analysis of social media language predicts addiction treatment dropout at 90 daysJun 23, 2023
  6. 09:27Oxytocin effects on amygdala reactivity to angry faces in males and females with ASPDApr 21, 2023
  7. 09:54To dismantle structural racism in science, scientists need to learn how it worksFeb 22, 2023
  8. 09:59Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activityDec 22, 2022
  9. 09:29Sex-dependent risk factors for PTSD: a prospective structural MRI studyNov 01, 2022
  10. 09:47Sex differences in appetitive and reactive aggressionSep 06, 2022